Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease

This publication has 23 references indexed in Scilit:

• High clopidogrel loading dose during coronary stenting: effects on drug response and interindividual variability
  European Heart Journal, 2004
• 807 C/T Polymorphism of the glycoprotein Ia gene and pharmacogenetic modulation of platelet response to dual antiplatelet treatment
  Blood Coagulation & Fibrinolysis, 2004
• Atorvastatin Does Not Affect the Antiplatelet Potency of Clopidogrel When It Is Administered Concomitantly for 5 Weeks in Patients With Acute Coronary Syndromes
  Circulation, 2004
• P2Y ₁₂ H2 Haplotype Is Associated With Peripheral Arterial Disease
  Circulation, 2003
• Resistance in vitro to low-dose aspirin is associated with platelet PlA1(GP IIIa) polymorphism but not with C807T(GP Ia/IIa) and C-5T kozak (GP Ibα) polymorphisms
  Journal of the American College of Cardiology, 2003
• Lack of Adverse Clopidogrel–Atorvastatin Clinical Interaction From Secondary Analysis of a Randomized, Placebo-Controlled Clopidogrel Trial
  Circulation, 2003
• Adenosine Diphosphate–Induced Platelet Aggregation Is Associated With P2Y ₁₂ Gene Sequence Variations in Healthy Subjects
  Circulation, 2003
• Atorvastatin Reduces the Ability of Clopidogrel to Inhibit Platelet Aggregation
  Circulation, 2003
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
  The Lancet, 1996
• Restriction site generating-polymerase chain reaction (RG-PCR) for the probeless detection of hidden genetic variation: application to the study of some common cystic fibrosis mutations
  Molecular and Cellular Probes, 1992